Perez, J. R. (2020) “Posterior Reversible Encephalopathy Syndrome (PRES) in a Patient Treated with a Novel Combination Treatment with Anti PDL1 Antibody (Durvalumab) and VEGFR2 Antibody (Ramucirumab)”, Archives of Clinical and Medical Case Reports, 4(1), pp. 8–14. Available at: https://fortunejournals.org/ojs/index.php/acmcr/article/view/22266 (Accessed: 15 June 2026).